Estimates of effects, ranking, and certainty of evidence for different treatment options vs placebo
Surufatinib (1 RCT; 198 participants)
Estimates of effects, ranking, and certainty of evidence for… probably leads to higher surufatinib (1 RCT; 198 participants) compared with placebo (moderate certainty).
2 findings from 1 review
- Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta‐analysis 2021 · Cochrane Headline outcomes onlyOR 3.5 [1.21, 10.1]1 study · 198 participantsModerate
- Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta‐analysis 2021 · Cochrane Headline outcomes onlyHR 0.33 [0.12, 0.88]1 study · 198 participantsModerate